Chromium is thought to enhance the action of insulin at the cellular level, supporting glucose uptake into cells. It is most commonly supplemented in the chelated "chromium picolinate" or amino acid chelate forms.
Clinical Summary
Clinical trials on chromium and glycemic control are mixed; a meta-analysis in the American Journal of Clinical Nutrition found no significant association between chromium supplementation and glucose or insulin levels in non-diabetic subjects, though effects may vary by population and dose.
Dosage Guidelines
Clinical trials have generally tested doses between 200mcg and 1,000mcg daily.
Safety & Side Effects
Very well tolerated; rare reports of mild headache or gastrointestinal upset.
Known Interactions
May enhance the effect of insulin or oral hypoglycemic medications, increasing the risk of hypoglycemia if not monitored.
Medical Disclaimer
The information provided in this clinical review is for educational and informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
*These statements have not been evaluated by the Food and Drug Administration (FDA). This product or ingredient is not intended to diagnose, treat, cure, or prevent any disease.
Always consult your physician or other qualified health provider with any questions you may have regarding a medical condition, or before beginning any new diet, fitness, supplement, or treatment regimen, especially if you have pre-existing medical conditions or are taking prescribed medications.
